Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
141.35B
Market cap141.35B
Price-Earnings ratio
18.59
Price-Earnings ratio18.59
Dividend yield
7.09%
Dividend yield7.09%
Average volume
42.81M
Average volume42.81M
High today
$24.94
High today$24.94
Low today
$24.85
Low today$24.85
Open price
$24.31
Open price$24.31
Volume
142.51K
Volume142.51K
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.11
52 Week low$23.11

Stock Snapshot

With a market cap of 141.35B, Pfizer(PFE) trades at $24.94. The stock has a price-to-earnings ratio of 18.59 and currently yields dividends of 7.09%.

During the trading session on 2026-07-16, Pfizer(PFE) shares reached a daily high of $24.94 and a low of $24.85. At a current price of $24.94, the stock is +0.4% higher than the low and still 0.0% under the high.

Trading volume for Pfizer(PFE) stock has reached 142.51K, versus its average volume of 42.81M.

The stock's 52-week range extends from a low of $23.11 to a high of $28.75.

The stock's 52-week range extends from a low of $23.11 to a high of $28.75.

PFE News

Seeking Alpha 22m
Pfizer, BioNTech face global patent suits from Arbutus, Roivant over COVID vaccine tech

Arbutus Biopharma (ABUS) and Genevant Sciences, a subsidiary of Roivant Sciences (ROIV), on Thursday announced the filing of three international lawsuits over a...

Pfizer, BioNTech face global patent suits from Arbutus, Roivant over COVID vaccine tech
TipRanks 46m
Arbutus initiates patent infringement actions against Pfizer, BioNTech

Arbutus Biopharma (ABUS) and its exclusive licensee, Genevant Sciences, a subsidiary of Roivant (ROIV), announced the filing of three international lawsuits see...

24/7 Wall St. 19h
Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price

Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price By Vandita Jadeja Published Jul 15, 1:29PM EDT Quick Read JNJ earns a B...

Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price

Analyst ratings

62%

of 29 ratings
Buy
31%
Hold
62.1%
Sell
6.9%

More PFE News

24/7 Wall St. 20h
Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King

This lithium producer surpassed a $1B private valuation, joining some of America's most powerful startups. Now you can invest in EnergyX alongside global giants...

Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King
Simply Wall St 2d
Pfizer Stock Looks Fully Priced After Its 21% Slump

Pfizer stock sits in an awkward middle ground for valuation right now, with a roughly 21% share price decline over five years set against checks that suggest th...

Pfizer Stock Looks Fully Priced After Its 21% Slump
24/7 Wall St. 2d
Pfizer Vs. Amgen: Bet That Pfizer's Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen

This lithium producer surpassed a $1B private valuation, joining some of America's most powerful startups. Now you can invest in EnergyX alongside global giants...

Pfizer Vs. Amgen: Bet That Pfizer's Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen
Nasdaq 2d
Pfizer Has the Highest-Yielding Dividend in the S&P 500. Should Investors Be Worried?

Key Points Pfizer's yield has fluctuated over the years due to its volatile share price. Its recent earnings numbers suggest the dividend is safe, but there i...

Pfizer Has the Highest-Yielding Dividend in the S&P 500. Should Investors Be Worried?
Nasdaq 2d
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb

Key Points Voluntary pricing deals reduce uncertainty for major drugmakers. Drug pricing pressure won't affect every pharmaceutical company equally. Strong p...

Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
Nasdaq 3d
Pfizer Advances While Market Declines: Some Information for Investors

Pfizer (PFE) closed the latest trading day at $26.61, indicating a +0.3% change from the previous session's end. The stock's performance was ahead of the S&P 50...

Pfizer Advances While Market Declines: Some Information for Investors
TipRanks 3d
Pfizer price target lowered to $30 from $34 at BMO Capital

BMO Capital lowered the firm’s price target on Pfizer (PFE) to $30 from $34 and keeps an Outperform rating on the shares as part of a broader research note prev...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.